NCT03183544View on ClinicalTrials.gov

Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

February 24, 2020

Study Completion Date

February 24, 2020

Conditions
Prostatic Neoplasm
Interventions
COMBINATION_PRODUCT

Gallium-68 PSMA-11 prepared using PSMA-11 Sterile Cold Kit

The patients will receive a single injection of Gallium-68 PSMA-11 to diagnose biochemical relapse of prostate cancer after treatment.

Trial Locations (1)

1200

Cliniques Universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT03183544 - Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit | Biotech Hunter | Biotech Hunter